Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | POLB | P06746 | 1/20 | 0.69 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 5/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.62 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | BCHE | P06276 | 1/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.62 |
| ▸ | NPC1 | O15118 | 1/20 | 0.61 |
| ▸ | HTT | P42858 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propyphenazone SCHEMBL7929540 | 0.98 | LMNA (0.97) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL11306629 | 0.89 | LMNA (0.81) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL11313942 | 0.89 | LMNA (0.81) | LMNAADORA3POLBPTGS2MEN1 | |
| Propyphenazone SCHEMBL28086369 | 0.88 | LMNA (0.81) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL28824167 | 0.86 | LMNA (0.76) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL6720188 | 0.85 | MEN1 (0.81) | LMNAADORA3POLBMEN1KMT2A | |
| SCHEMBL11319112 | 0.85 | LMNA (0.73) | LMNAADORA3POLBPTGS2MEN1 | |
| Propyphenazone SCHEMBL27899010 | 0.84 | LMNA (0.70) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL18084405 | 0.83 | LMNA (0.71) | LMNAADORA3POLBPTGS2MEN1 | |
| SCHEMBL15614523 | 0.83 | LMNA (0.71) | LMNAADORA3POLBPTGS2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4418 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260083666-A1 | METHOD OF TREATING DISEASE | CREWS THOMAS M (US) | 2026-03-26 | — | — | US | claimed |
| EP-4679085-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20250058025-A1 | A THREE-DIMENSIONAL BIOCOMPATIBLE MATRIX AND ITS USES IN WOUND MANAGEMENT | AXENOLL LIFE SCIENCES AG (CH) | 2025-02-20 | — | — | US | claimed |
| CN-119303086-A | Pharmaceutical composition for treating autism | 斯塔利克拉股份有限公司 | 2025-01-14 | — | — | CN | claimed |
| EP-4452349-A1 | A THREE-DIMENSIONAL BIOCOMPATIBLE MATRIX AND ITS USES IN WOUND MANAGEMENT | Axenoll Life Sciences AG (CH) | 2024-10-30 | — | — | EP | claimed |
| WO-2024190666-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| US-20240269115-A1 | PYRAZOLONE COMPOUNDS FOR USE IN DEGENERATIVE RETINAL DISEASES | FLONEXT S.R.L. (IT) | 2024-08-15 | — | — | US | claimed |
| EP-0792371-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-09-03 | — | — | EP | claimed |
| EP-0786999-A1 | COMBINATION METHOD FOR ACNE TREATMENT | Merck & Co., Inc. (US) | 1997-08-06 | — | — | EP | claimed |
| CN-1142766-A | Antipyretic analgesic combination medicament | FUJIZAWA PHARMACEUTICAL CO LTD (JP) | 1997-02-12 | — | — | CN | claimed |
| US-5543417-A | 5 Alpha-reductase inhibitor and at least one of an antibacterial agent, a keratolytic agent or an anti-inflammatory agent | MERCK & CO., INC. (US) | 1996-08-06 | — | — | US | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| EP-0272638-B1 | ANALGESIC PREPARATION | F. HOFFMANN-LA ROCHE AG (CH) | 1992-05-20 | — | — | EP | claimed |
| US-4540602-A | Process for the preparation of activated pharmaceutical compositions | FREUND INDUSTRY COMPANY, LIMITED (JP) | 1985-09-10 | — | — | US | claimed |
| EP-0007572-B1 | PHARMACEUTICAL MIXTURES CONTAINING AN AMANTADINE COMPOUND | CIBA-GEIGY AG (CH) | 1983-04-27 | — | — | EP | claimed |
| US-4181719-A | Analgesic N-acetyl-para-aminophenyl N'-acetylaminothioalkanoates | STERLING DRUG INC. (US) | 1980-01-01 | — | — | US | claimed |